Evidence map›Paper›PMID 30837959›Full record

ArticleFrontiers in microbiology2019

Comparison of the Vaginal Microbiomes of Premenopausal and Postmenopausal Women.

Karol Gliniewicz, G Maria Schneider, Benjamin J Ridenhour, Christopher J Williams, Yuli Song, Miranda A Farage, Kenneth Miller, Larry J Forney

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05122065 (Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy), which is not on this map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05122065 unknown statusnot on this mapstarted 2021, after this paper: background citation

Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy

TypeobservationalSponsorFemTec Health Inc.Ran2021 to 2022Enrolled432ConditionsMenopause, Hormone Replacement Therapy, Genitourinary Syndrome of Menopause
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 137 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Gut Microbiome and Estrogen.Journal of menopausal medicine · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Aging Is Associated With Decreased Lactobacillus and Increased Cervicovaginal Inflammation in Canadian Women.American journal of reproductive immunology (New York, N.Y. : 1989) · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Karol GliniewiczDepartment of Biological Sciences, University of Idaho, Moscow, ID, United States.
G Maria SchneiderDepartment of Biological Sciences, University of Idaho, Moscow, ID, United States.
Benjamin J RidenhourDepartment of Biological Sciences, University of Idaho, Moscow, ID, United States.
Christopher J WilliamsDepartment of Statistical Science, University of Idaho, Moscow, ID, United States.
Yuli SongThe Procter and Gamble Company, Cincinnati, OH, United States.
Miranda A FarageThe Procter and Gamble Company, Cincinnati, OH, United States.
Kenneth MillerThe Procter and Gamble Company, Cincinnati, OH, United States.
Larry J ForneyDepartment of Biological Sciences, University of Idaho, Moscow, ID, United States.
University of Idaho · USProcter & Gamble (United States) · US

Funding

Genomics Resources Core (GRC)P30GM103324 · NIGMS · UNIVERSITY OF IDAHO · PI SETTLES, MATTHEW · 2013 to 2017
$5.0M
NIGMS NIH HHS P30 GM103324
6 · The paper itself

Abstract

For decades hormone therapy (HT) has been prescribed to treat the symptoms of menopause, such as vaginal dryness, itching and burning. Here we sought to compare the vaginal microbiomes of postmenopausal women who received low dose estrogen therapy to those of premenopausal and postmenopausal women, and to do so in conjunction with assessing the alleviation of symptoms associated with vaginal atrophy. In this study vaginal swab samples were obtained from 45 women who were classified as either premenopausal, postmenopausal, or postmenopausal and undergoing HT. The vaginal microbiomes of these women were characterized by

Indexed as

hormone replacement therapymenopausemicrobial community structure and functionpremenopausevaginal atrophyvaginal microbiome

Identifiers

PMID30837959
PMCPMC6382698
OpenAlexW2913026406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.